NOX vs PAR

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

NOX

NOXOPHARM FPO [NOX]

55MEDIUM

PAR

PARA BIO FPO [PAR]

48LOW

Score Breakdown

NOX PAR
Technical
46
53
Catalyst
50
51
Sentiment
50
50
Fundamental
39
60
Momentum
60
42
Risk Gate
46
50

Key Metrics

NOX Metric PAR
$26.1MMarket Cap$99.4M
168KAvg Volume (20d)2.2M
N/AShort InterestN/A
$0.13552-Week High$0.470
$0.04652-Week Low$0.135
+4.7%Daily Change-7.4%
$0.089Reference Price$0.162
-343.6%ROE-180.2%
-161.7%Profit MarginN/A

Active Signals

NOX Signals

●MACD momentum is losing steam
●Watch out — volume is flowing out even as price holds up. Distribution pattern
●Drifting lower — down 6.8% over the last 5 days
●Beating the Small Ords index — relative strength of 1.26, so it's outpacing the pack
●Trading above the 200-day average — the long-term trend is on your side
●Critical cash runway (0.1 quarters)
●Moderate P/S ratio (7.7x)
●Strong revenue growth (+50%)

PAR Signals

●RSI drifting toward oversold territory — worth watching
●Bollinger Bands are tightening — volatility is coiling up for a potential breakout
●Drifting lower — down 4.7% over the last 5 days
●Volatility is contracting — like a spring being compressed, breakouts often follow
●Below the 200-day average — the long-term trend is still working against it
●Low cash runway (2 quarters) - dilution risk
●Very high P/S ratio (11766.1x)
●Strong revenue growth (+51%)

Ask Scout AI to compare NOX and PAR in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

NOX vs SPL →NSB vs NTI →NSB vs NXN →NSB vs PAR →NSB vs SNT →
NOX Full Analysis → PAR Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).